Gills Quoted in Crain’s Chicago Business about Law Firm Diversity
December 15, 2017
Crain's Chicago Business
Partner Jeanne Gills was quoted in a Crain’s Chicago Business article, “Chicago Lawyers: Not A Diverse Lot” about the lack of diversity in Chicago law firms. According to Crain’s, Chicago law firms have a lower percentage of minority partners and junior lawyers than peer cities including New York, Washington, DC, Houston and Los Angeles.
Gills, who is also the president of the Chicago Black Partners Alliance, said minority lawyers’ underrepresentation in the Chicago bar stems from the same forces as found elsewhere in the country: unconscious bias and limited access to big clients and complex cases, which hampers career advancement.
Gills, who is also the president of the Chicago Black Partners Alliance, said minority lawyers’ underrepresentation in the Chicago bar stems from the same forces as found elsewhere in the country: unconscious bias and limited access to big clients and complex cases, which hampers career advancement.
People
Related News
August 13, 2025
In the News
Leigh Riley on Elevating Partner Development with Foley's PEAK Program – 'We can't stop learning'
Foley & Lardner LLP partner Leigh Riley appeared on the Big Law Life podcast to share how Foley is redefining professional development to meet the needs of the firm's partners and the demands of modern legal practice.
August 8, 2025
In the News
Gregory Husisian and David Simon Uncover the High Stakes of Tariff Evasion
Foley & Lardner LLP partners Gregory Husisian and David Simon are featured for their insights on how the U.S. government is cracking down on tariff evaders in the Newsweek article, "America Is Making Billions From Catching 'Tariff Cheaters.'"
August 7, 2025
In the News
Kyle Faget Weighs in on Trump Pharma Tariffs
Foley & Lardner LLP partner Kyle Faget assessed the Trump administration's implementation of import tariffs on the pharmaceutical industry in the Pharma Life Sciences article, "Trump's pharma import tariffs threaten drug pricing, generics."